Silanization improves biocompatibility of graphene oxide

Area of Science:

• Biomaterials Science
• Nanotechnology
• Materials Chemistry

Background:

• Graphene oxide (GO) has potential biomedical applications.
• Evaluating the biological properties of modified GO is crucial for its safe use.
• Silanization is a common modification technique.

Purpose of the Study:

• To evaluate the toxicity, immunogenicity, and osteogenicity of silanized graphene oxide (SiGO).
• To compare the biological properties of SiGO with unmodified GO.
• To assess the potential of SiGO as a biocompatible material.

Main Methods:

• Graphene oxide (GO) was silanized using (3-aminopropyl) triethoxysilane (APTES).
• Silanization was confirmed using infrared spectroscopy and elemental mapping.
• In vitro toxicity, immunogenicity, and osteogenicity assays were performed on various cell lines.
• Acute toxicity was assessed in a murine model.

Main Results:

• Silanization did not significantly alter GO morphology but increased interlayer distance and lattice disorder.
• SiGO showed significantly lower in vitro toxicity and macrophage immune activation compared to GO.
• SiGO exhibited reduced osteogenic differentiation potential compared to GO.
• Acute toxicity studies revealed GO was hepatotoxic, while SiGO showed no significant toxicity.

Conclusions:

• Silanized graphene oxide (SiGO) demonstrates improved biocompatibility over unmodified graphene oxide (GO).
• SiGO presents a safer alternative to GO for biomedical applications due to reduced toxicity and immunogenicity.
• Further research into SiGO's specific applications is warranted based on its enhanced biocompatibility.